|
FY2026
12 months to Feb 28, 2026
|
FY2025
12 months to Feb 28, 2025
|
FY2024
12 months to Feb 29, 2024
|
FY2023
12 months to Feb 28, 2023
|
FY2022
12 months to Feb 28, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Revenues | |||||
| Cost of sales | |||||
| Cost of Revenue | |||||
| Gross margin | |||||
| Operating expenses | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Amortization | |||||
| Impairment of goodwill | |||||
| Goodwill impairment loss continuing operations | |||||
| Impairment of long-lived assets (note 4) | |||||
| Gain on sale of property, plant and equipment, net | |||||
| Prior Debentures fair value adjustment | |||||
| Litigation settlement | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Investment income, net (note 4 and note 7) | |||||
| Income before income tax | |||||
| Provision for income taxes (note 6) | |||||
| Consolidated income from continuing operations before income taxes | |||||
| Gain from disposal of discontinued operation, net of tax (note 3) | |||||
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax | |||||
| Net income (loss) | |||||
| Earnings (loss) per share (note 9) | |||||
| Earnings Per Share, Basic | |||||
| Earnings Per Share, Diluted | |||||
| Diluted earnings (loss) per share from continuing operations | |||||
| Basic earnings (loss) per share from continuing operations | |||||
Loading...
